£148.36

Springer Neurochemical Aspects of Excitotoxicity

Price data last checked 47 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£148 today · previous high £148 · all-time low £144

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 44 days • 30 data points (No recent data available)

Historical
Generating forecast...
£148.36 £143.10 £144.25 £145.40 £146.54 £147.69 £148.84 14 March 2026 24 March 2026 04 April 2026 15 April 2026 26 April 2026

Price Distribution

Price distribution over 44 days • 2 price levels

Days at Price
Current Price
4 days 26 days · current 0 7 13 20 26 £144 £148 Days at Price

Price Analysis

Most common price: £148 (26 days, 86.7%)

Price range: £144 - £148

Price levels: 2 different prices over 30 days

Description

Leading researchers offer cutting-edge information on glutamate metabolism in the brain, examining the role of glutamate transporters and the involvement of glutamate receptors in the pathogenesis of acute neural trauma and neurodegenerative diseases. In addition, the authors discuss the treatment of these diseases with endogenous and exogenous antioxidants and glutamate receptor antagonists. From the Back Cover About 40% of central nervous system synapses use glutamate as the neurotransmitter. Over-stimulation of glutamate receptors produces neuronal injury or death by excitotoxicity, which is closely associated with neurochemical and neuropathological changes involved in acute neural trauma (stroke, spinal cord trauma, and head injury) and neurodegenerative diseases such as Alzheimer disease, Parkinson disease, Huntington disease, amyotrophic lateral sclerosis (ALS), Creutzfeldt-Jakob disease, Guam-type amyotrophic lateral sclerosis/Parkinson dementia (ALS/PDC), and multiple sclerosis. In the past decade, our understanding of the biochemistry, molecular biology, and neuropathology of the glutamate transporters and receptors has exploded. It is becoming increasingly evident that molecular mechanisms, which govern the transfer of the death signal from the neural cell surface to the nucleus, depend on lipid mediators and on cross talk among excitotoxicity, oxidative stress, and neuroinflammation, and that interactions among these three processes play a major role in neuronal cell death during acute neural trauma and neurodegenerative disease. These processes may be primary initiating points in neurodegeneration or they may be the end result of the neurodegenerative process itself. Neurochemical Aspects of Excitotoxicity provides extensive insight into glutamate transporters and receptors, including their role in the brain with other neurochemical parameters in excitotoxicity, and possible treatments. This book will be of interest to scientists already working in the field of excitotoxicity who are interested in gaining a broader understanding of this complicated subject area, as well as graduate students and neurologists who are curious about a common cause of neuronal injury and neurological disorders. About the Authors: Akhlaq A. Farooqui, Wei-Yi Ong, and Lloyd A. Horrocks are leaders in the field of glycerophospholipid metabolism mediated by glutamate in neural membranes. They have reported the stimulation of isoforms of phospholipases A2 caused by glutamate toxicity and increased activities of phospholipases A2 in brains from patients with Alzheimer disease. They have published cutting edge research on kainate-mediated alterations in glycerophospholipid, sphingolipid, and cholesterol-derived lipid mediators during excitotoxicity. Akhlaq A. Farooqui and Lloyd A. Horrocks are the authors of the monograph, Glycerophospholipids in the Brain: Phospholipases A2 in Neurological Disorders (Springer 2007). Lloyd A. Horrocks is the founding editor of the journal Molecular and Chemical Neuropathology, and has edited seven other books.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Molecular Aspects of Neurodegeneration, Neuroprotection, and Regeneration in Neurological Disorders
97% match

Molecular Aspects of Neurodegeneration, Neuroprotection, and Regeneration in Neurological Disorders

Academic Press

£101.89 26 Jan 2026
Neuroinflammation, Resolution, and Neuroprotection in the Brain
97% match

Neuroinflammation, Resolution, and Neuroprotection in the Brain

Academic Press

£101.29 09 Mar 2026
Beneficial Effects of Fish Oil on Human Brain
96% match

Beneficial Effects of Fish Oil on Human Brain

Springer

£135.10 27 Jan 2026
Excitotoxicity in Neurological Diseases: New Therapeutic Challenge
96% match

Excitotoxicity in Neurological Diseases: New Therapeutic Challenge

Springer

£110.62 12 Jun 2026
Beneficial Effects of Fish Oil on Human Brain
96% match

Beneficial Effects of Fish Oil on Human Brain

Springer

£202.26 25 Apr 2026
Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases
96% match

Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases

Springer

£179.99 22 Jan 2026
Molecular Biology and Brain Ischemia
96% match

Molecular Biology and Brain Ischemia

Springer

£62.66 23 Apr 2026
Glutamate Receptors in Peripheral Tissue: Excitatory Transmission Outside the CNS (Endocrine Updates S)
96% match

Glutamate Receptors in Peripheral Tissue: Excitatory Transmission Outside the CNS (Endocrine Updates S)

Springer

£44.48 24 Jan 2026
Humana - The Metabotropic Glutamate Receptors Book
96% match

Humana - The Metabotropic Glutamate Receptors Book

Humana

£113.48 20 Apr 2026
Excitatory Amino Acids: Clinical Results with Antagonists
96% match

Excitatory Amino Acids: Clinical Results with Antagonists

Academic Press

£128.21 13 Jan 2026
EXCITOTOXICITY FUNDAMENTAL: Fundamental Concepts, Pathophysiology & Treatment Strategies (Neuroscience Research Progress)
96% match

EXCITOTOXICITY FUNDAMENTAL: Fundamental Concepts, Pathophysiology & Treatment Strategies (Neuroscience Research Progress)

£38.76 28 Feb 2026
The Glutamate/GABA-Glutamine Cycle: Amino Acid Neurotransmitter Homeostasis: 13 (Advances in Neurobiology, 13)
96% match

The Glutamate/GABA-Glutamine Cycle: Amino Acid Neurotransmitter Homeostasis: 13 (Advances in Neurobiology, 13)

Springer

£145.51 09 Mar 2026
Cellular Regulation of Glutamate Receptors in Central Neurons: Intracellular Signaling, Receptor Trafficking, Protease Proteolysis
96% match

Cellular Regulation of Glutamate Receptors in Central Neurons: Intracellular Signaling, Receptor Trafficking, Protease Proteolysis

VDM Verlag

£57.65 13 Jan 2026
Humana The Ionotropic Glutamate Receptors - Medical Book
96% match

Humana The Ionotropic Glutamate Receptors - Medical Book

Humana

£71.68 22 Apr 2026
Congenital Neurotransmitter Disorders: A Clinical Approach
95% match

Congenital Neurotransmitter Disorders: A Clinical Approach

£161.00 24 Apr 2026
Neuroglia in Neurodegenerative Diseases: 1175 (Advances in Experimental Medicine and Biology, 1175)
95% match

Neuroglia in Neurodegenerative Diseases: 1175 (Advances in Experimental Medicine and Biology, 1175)

Springer

£122.05 09 Mar 2026
Neuroglia in Neurodegenerative Diseases: 1175 (Advances in Experimental Medicine and Biology, 1175)
95% match

Neuroglia in Neurodegenerative Diseases: 1175 (Advances in Experimental Medicine and Biology, 1175)

Springer

£128.11 25 Apr 2026
Humana Glutamate Receptors: Methods and Protocols 1941
95% match

Humana Glutamate Receptors: Methods and Protocols 1941

Humana

£93.93 26 Apr 2026
New Technologies for Glutamate Interaction: Neurons and Glia: 207 (Neuromethods, 207)
95% match

New Technologies for Glutamate Interaction: Neurons and Glia: 207 (Neuromethods, 207)

£147.00 12 Jan 2026
mGLU Receptors: 31 (The Receptors, 31)
95% match

mGLU Receptors: 31 (The Receptors, 31)

Humana

£107.49 27 Apr 2026
Dopamine and Glutamate in Psychiatric Disorders
95% match

Dopamine and Glutamate in Psychiatric Disorders

Humana

£157.45 24 Apr 2026
Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)
95% match

Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)

Humana

£104.04 27 Feb 2026
Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)
95% match

Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)

Humana

£80.28 22 Feb 2026
The Glutamate Synapse as a Therapeutic Target (Volume 116) (Progress in Brain Research, Volume 116)
95% match

The Glutamate Synapse as a Therapeutic Target (Volume 116) (Progress in Brain Research, Volume 116)

Elsevier

£148.39 10 Mar 2026